HOME >> MEDICINE >> NEWS
Treatment response to Aricept® (donepezil hydrochloride) not predicted by Apolipoprotein E4 genotype or gender

WASHINGTON, D.C. 11 July, 2000 -- Aricept® (donepezil hydrochloride) demonstrated beneficial effects on cognition and global function over the course of one year in a double-blind, placebo-controlled, multinational study in patients with mild to moderate Alzheimer's disease (AD). In this study, treatment response was not predicted by Apolipoprotein E4 (ApoE4) genotype and/or gender, according to data presented today at the World Alzheimer Congress in Washington D.C.

ApoE is a lipoprotein that carries cholesterol in the blood. The exact role the ApoE4 allele plays in the pathogenesis of AD or in the memory decline of cognitively impaired elderly is unclear presently. Furthermore, much of the evidence concerning a correlation between ApoE4 copy number and the pathological features of AD (e.g. neuronal plaque density and the appearance of neurofibrillary tangles) is contradictory. It has been suggested that patients carrying an ApoE4 allele may have a more severe cholinergic deficit than those who do not.

"The reports of associations between ApoE4 genotype, gender and response to cholinesterase inhibitor therapy in AD patients are conflicting. In this recently completed study, a secondary analysis showed that the treatment response to ARICEPT®, a cholinesterase inhibitor, was not predicted by ApoE4 genotype and/or gender in patients with mild to moderate AD," says Hilkka Soininen, M.D., Ph.D., University of Kuopio, Kuopio, Finland.

This one-year multinational, double-blind, placebo-controlled study enrolled 286 patients with mild to moderate AD from 28 sites in five Northern European countries (Denmark, Finland, Norway, Sweden and The Netherlands). Patients were randomized to receive either ARICEPT® (n=142; 5 mg/day for 28 days, and then 10 mg/day) or placebo (n=144) for one year. The mean age of the patients enrolled in the study was 72.5 (range: 49-88 years).

Outcomes measures included evaluation of global function (the Gottf
'"/>

Contact: Celeste Torello, Pfizer Inc.
212-733-6471
Porter Novelli
10-Jul-2000


Page: 1 2

Related medicine news :

1. Treatment of cardiac lesions without anaesthesic
2. Treatment guidelines for kids with bipolar disorder published
3. University of Washington joins new Autism Treatment Network to provide better medical services
4. Treatment for brain tumor does not always follow recommendations
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Treatment of ductal carcinoma in situ varies widely in United States
7. Treatment options expand for patients with neuropathic pain
8. Treatment interruption shows no benefit in drug-resistant HIV infection
9. Peanut Allergy: Major Advances in Treatment and Education
10. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
11. Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control

Post Your Comments:
(Date:3/31/2015)... March 31, 2015 The New ... Care Administrators (ACHCA) elected two administrators from Windsor ... long-term care in New Jersey, to two key ... new officers. Robert Reyes, administrator for Abingdon Care ... president, and Yael Herman, administrator of Canterbury Care ...
(Date:3/31/2015)... March 31, 2015 Williams Comfort ... repair visit when their home comfort is at ... make the visit fit into the customer’s schedule, ... fast, quality repair at requested times. , ... commercial customers in the Indianapolis area can visit ...
(Date:3/31/2015)... 31, 2015 Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ... developed new-onset Type 2 diabetes due to the use ... the federal multidistrict litigation now underway in U.S. District ... issued on March 26th, jury selection for the proceeding’s ... (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502) , ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 ... Practice Edition 2, bringing the industry’s most advanced ... the healthcare community. Physicians can now experience the ... a trusted source, offering value-added support services that ... (EHR) systems. , “QMedET is proud to provide ...
(Date:3/31/2015)... CirugiaPlastica-Mexico.net , an exclusive plastic ... company, announced today an expansion of providers in ... most experienced and committed plastic surgeons in Mexico, ... elegant, life-altering cosmetic enhancements. Overall, a larger number ... in Mexico due to the improved technology, greater ...
Breaking Medicine News(10 mins):Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 2Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 3Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 3Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 4
(Date:3/31/2015)... PARIS , March 31, 2015 ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced ... CHU de Grenoble (university hospital center). The CHU de ... France to propose to its gastroenterology, interventional ... research and a higher standard of care thanks to ...
(Date:3/31/2015)... Mar. 30, 2015 Research and Markets ... of the "Eurpoean Automatic External Defibrillators (AED) ... Public Access Market, Hospitals, Alternate Care Market, Home) ... offering. The European automated external defibrillator ... CAGR of 10.9% from 2014 to 2019 ...
(Date:3/31/2015)... Mich. , March 31, 2015  The efficacy ... was highlighted in a recently published study 1 ... infection prevention research team, including Curtis Donskey , ... was run for the same length of time from ... xenon (PU-UV) unit.  The results showed surprisingly low pathogen ...
Breaking Medicine Technology:Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 2Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 3Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4
Cached News: